熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
日本Chiome Bioscience
Chiome公司,擅長于抗體技術(shù),稱其技術(shù)平臺(tái)具有"加速藥物發(fā)現(xiàn)及推進(jìn)醫(yī)藥開發(fā)"的潛能。該公司的"自主多元化文庫(Autonomously Diversifying Library,ADLib)"系統(tǒng),能夠快速地產(chǎn)生抗體,在實(shí)驗(yàn)室環(huán)境下僅需短短10天時(shí)間。
Chiome is a Japan-based biotech company specialized in antibody and technology development. It has developed an innovative and unique platform technology, ADLib?system, to which right Chiome co-owns with RIKEN Institute. Since 2008, it has been engaged in joint research and the generation of antibodies with a number of leading domestic and multinational pharmaceutical and diagnostic companies. Chiome offers ADLib?system to partners under a non-exclusive license to maximize the value of the technology. By leveraging this proprietary technology Chiome Bioscience believes it can make great contributions to pharmaceutical development.